2 September 2010

Financial Objects eyes fruitful future

BUY

09/10/2006 Andrew Hore

The successful integration of two acquisitions has transformed the fortunes of software house Financial Objects, giving the now-profitable group a wider suite of products to sell, a broader range of clients to target and a healthy forward order book.

Like all small company survivors, Financial Objects has a colourful history. For the first ten years of its existence it was purely a banking software provider, offering front and back office products to around 600 customers. This was a nice line of business that unfortunately peaked in 1999, from which point the group drifted into losses.

However, in May 2005, the company acquired Wealth Management Software, following this up in March 2006 with the purchase of risk management software supplier Raft International.

WMS has broadened the customer base in the financial services sector and provided Financial Objects with software it can cross-sell to its existing customers. The Raft purchase added to the group’s range of risk management products, a growth area because of the increased emphasis on compliance. Raft’s particular area of expertise is in risk software for energy and utility companies – two buoyant sectors.

In addition to all of this, Financial Objects has a software development centre in Bangalore, the city known as the Silicon Valley of India. This started trading three years ago and staff numbers have increased to more than 130, with the lower cost of development helping the group to compete.

In the six months to June, turnover increased 87 per cent to £10.5 million and profit before amortisation and exceptionals increased from £251,000 to £1 million. Even stripping out the effect of the acquisitions of Wealth Management Software and Raft International, organic sales growth was 20 per cent. Recurring revenues made up two-fifths of group turnover.

First-half growth was mainly down to a strong performance from banking software. That improvement does not look repeatable in the second half. The growth will come from the other activities in the rest of the year.

The Raft energy risk software business made a loss in the four months it was included in the first half. But it signed a large contract in June and this, as well as other imminent contracts, will help the business perform more strongly in the rest of the year. WMS also signed up customers that will generate more revenues in the second half. There was a problem with a contract won just after WMS was acquired, but management has apparently learnt from this mistake.

As things stand, the group order book is worth £13.5 million, with Raft accounting for £2.5 million of that. Net debt was £223,000 at the end of June but the group should return to a net cash position by the year end. Raft’s Danish consultancy business appears non-core and if it were sold it could further boost the cash position.

Underlying profits are forecast to almost double from £1 million to £2 million in the full year. Profits could rise to £2.6 million in 2007. Financial Objects also has £11 million of
tax losses, so it won’t be paying much in the way of tax for the foreseeable future.

Broker Evolution believes tax losses alone are worth 7p. And the shares trade on less than ten times forecast earnings for 2006 – based on a nil tax charge – falling to eight in 2007. There is also the chance of a dividend for the first time since 2003. A 0.5p a share payment would give the shares a 1.1 per cent yield and acquisition benefits will show through over the next couple of years. All of this should prompt a re-rating. Buy.

Sector: Software & Computer Services

Companies: Financial Objects

Subscribe today


More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.

Subscribe today and save 50%

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.

Popular Recommendations

Latest Recommendations

Delcam 01/09/2010

Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.

Antisoma 01/09/2010

Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.

GW Pharmaceuticals 31/08/2010

GW Pharmaceuticals has won approval from Health Canada for its cannabis-based Sativex product to treat spasticity caused by Multiple Sclerosis.

More Recommendations

Sectors

Vitesse Media Events